Found: 14
Select item for more details and to access through your institution.
Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology Editorial.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Antispasmodic effects of essential oil of Pterodon polygalaeflorus and its main constituent β-caryophyllene on rat isolated ileum V. Leonhardt et al. Antispasmodic effects of essential oil of Pterodon polygalaeflorus.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 749, doi. 10.1111/j.1472-8206.2009.00800.x
- By:
- Publication type:
- Article
Gender differences in the cardiovascular effects of sex hormones C. Vitale et al. Gender and cardiovascular effects of sex hormones.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 675, doi. 10.1111/j.1472-8206.2010.00817.x
- By:
- Publication type:
- Article
Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention M. Lombardi et al. Gender aspects in cardiovascular prevention.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 699, doi. 10.1111/j.1472-8206.2010.00834.x
- By:
- Publication type:
- Article
Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline B. Haenisch et al. Receptor pharmacology of oxymetazoline.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 729, doi. 10.1111/j.1472-8206.2009.00805.x
- By:
- Publication type:
- Article
Themed series article list.
- Published in:
- 2010
- Publication type:
- Editorial
Hepatic effects of flunixin-meglumin in LPS-induced sepsis T.V. Ávila et al. Flunixin-meglumin in LPS-induced sepsis.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 759, doi. 10.1111/j.1472-8206.2009.00804.x
- By:
- Publication type:
- Article
Gender-specific aspects in the clinical presentation of cardiovascular disease C. Leuzzi et al. Clinical gender-difference cardiovascular disease.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 711, doi. 10.1111/j.1472-8206.2010.00873.x
- By:
- Publication type:
- Article
Management of acute coronary syndromes from a gender perspective J. Alfredsson & E. Swahn Treatment in ACS.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 719, doi. 10.1111/j.1472-8206.2010.00837.x
- By:
- Publication type:
- Article
Gender and the renin-angiotensin-aldosterone system K. Komukai et al. Gender and RAAS.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 687, doi. 10.1111/j.1472-8206.2010.00854.x
- By:
- Publication type:
- Article
Gender differences in the treatment of chronic ischemic heart disease: prognostic implications G. Ciambrone & J.C. Kaski A current problem with prognostic implications.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 707, doi. 10.1111/j.1472-8206.2009.00774.x
- By:
- Publication type:
- Article
Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes S. Álvarez et al. Dopamine metabolism and transport genes in schizophrenia.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 741, doi. 10.1111/j.1472-8206.2009.00807.x
- By:
- Publication type:
- Article
Gender-specific features of plasmatic and circulating cell alterations as risk factors in cardiovascular disease E. Straface et al. Gender and cardiovascular biomarkers.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 665, doi. 10.1111/j.1472-8206.2010.00860.x
- By:
- Publication type:
- Article
Antioxidative mechanisms protect resistant strains of Staphylococcus aureus against ciprofloxacin oxidative damage P.L. Páez et al. Antioxidative mechanisms in Staphylococcus aureus.
- Published in:
- Fundamental & Clinical Pharmacology, 2010, v. 24, n. 6, p. 771, doi. 10.1111/j.1472-8206.2009.00806.x
- By:
- Publication type:
- Article